Events2Join

Piet van der Graaf and Kathleen Giacomini


The Pandemic as a Catalyst for Disruptive Innovation in Clinical ...

Authors. Kathleen M Giacomini , Piet H van der Graaf. Affiliations. 1 University of California San Francisco, San Francisco, California, USA. 2 Certara ...

Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic ...

Authors. Kathleen M Giacomini , Piet H van der Graaf. Affiliations. 1 Department of Bioengineering and Therapeutic Sciences, University of California ...

Piet van der Graaf and Kathleen Giacomini - Certara

Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. ... Our Certara Code of Conduct ensures that we ...

Piet H. van der Graaf's research works | University of Kent and other ...

Kathleen Giacomini. ·. Piet H. van der Graaf ... We encoded the model structure in QSP Designer [46] and employed Nelder-Mead method for parameter estimation ...

COVID‐19: A Defining Moment for Clinical Pharmacology ...

... Access COVID‐19: A Defining Moment for Clinical Pharmacology? Piet H. van der Graaf, Kathleen M. Giacomini Pages: 11-15 First Published:29 April 2020.

The Pandemic as a Catalyst for Disruptive Innovation in Clinical ...

As an example, where GenAI helped to foster innovation. This disruptive innovation (Giacomini and van der Graaf, 2022) , was invented with the assistance of ...

Kathleen M. Giacomini (0000-0001-8041-5430) - ORCID

Kathleen M. Giacomini; Piet H. van der Graaf; Richard W. Peck. Show more detail. Source: check_circle. Crossref. TICBase: Integrated Resource for Data on Drug ...

Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic ...

Piet H. van der Graaf, PharmD, PhD and Kathleen M. Giacomini, PhD 9:36 AM - 9:42 AM MT Pharmacogenetics Consortia Perspective Henk-Jan Guchelaar, PharmD ...

Kathy Giacomini, PhD - UCSF Profiles

Trends in Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther. 2023 07; 114(1):11-14. Minichmayr IK, Smith DM, Giacomini KM, van der Graaf PH ...

The Pandemic as a Catalyst for Disruptive Innovation in Clinical ...

Giacomini1,* and Piet H. van der Graaf2,3. Disruptive innovation, the theme ... van der Graaf, P.H. & Giacomini, K.M.. COVID- 19: a defining moment for ...

Special ASCPT News - 2020 CPT Editorial Team Announced

Piet van der Graaf, PhD, PharmD · Kathleen Giacomini, PhD · Karthik Venkatakrishnan, PhD · Alexander Vinks, PharmD, PhD · Ingolf Cascorbi, MD, PhD.

Piet van der Graaf and Kathleen Giacomini - Certara

Piet van der Graaf and Kathleen Giacomini ... Please find the Certara privacy policy here. You can unsubscribe, and withdraw your consent, at any time.

OpenURL Connection Search - EBSCO

Giacomini, Kathleen M.;; van der Graaf, Piet H.;; Peck, Richard W. Publication type: Article. Select item. TICBase: Integrated Resource for Data on Drug and ...

Kathy Giacomini, PhD, BSPharm

Kathy Giacomini, PhD, BSPharm. Co-Principal Investigator, UCSF-Stanford ... Giacomini KM, van der Graaf PH. Rare Diseases Linked to Mutations in Vitamin ...

ISSX News Brief - MultiBriefs

Is pharmacogenetic testing a vital tool for enhancing therapeutic management of patients worldwide? Kathleen M. Giacomini, Piet H. van der Graaf via American ...

I am ASCPT: Karen Brown

... Piet van der Graaf, PharmD, PhD, and Kathleen Giacomini, PhD. I feel like I have learned so much about the backend of the publication ...

Altmetric – Ensuring Transparency and Quality of Clinical Trial ...

Standing, Kathleen M. Giacomini, Piet H. van der Graaf, Richard W. Peck [show]. View on publisher site Alert me about new mentions. Timeline. X Demographics.

Publication: Progress in Clinical Pharmacology in China: A ...

... -Guided Precision Medicine. Liang Zhao Kathleen M Giacomini Piet H van der Graaf. Published in: Clinical pharmacology and therapeutics (2024). Keyphrases.

Piet H. van der Graaf - Scilit

Kathleen M. Giacomini. Department of Bioengineering and Therapeutic Sciences University of California San Francisco San Francisco California USA. Lambertus A ...